BELL TOWER
Board
2 directors, last change in 2021LOSANE BV
Statutory director, permanent representative Carlos de Meester de Betzenbroeck
appointed by deed of 23-07-2021
term without a fixed end
also on the board of 27 other companies
listed in the 2025 annual accounts, filed on 23-06-2026
ROSHECO BV
Director (not named in the articles), permanent representative Xavier de Jacquier de Rosée
appointed by deed of 23-07-2021
term without a fixed end
also on the board of 18 other companies
listed in the 2025 annual accounts, filed on 23-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “domicilié à 1170 Watermael-Boitsfort, Avenue Léopold Wiener 61. L'assemblée décide que chaque administrateur agit seul.”deed of 23-07-2021
Permanent representatives 2
Permanent representative, for LOSANE
appointed by deed of 23-07-2021
Mandates through the years
3 names, the dashed line is todayLOSANE
Statutory director
Statutory director
ROSHECO
Director (not named in the articles)
Director (not named in the articles)
Carlos de Meester de Betzenbroeck
Manager and director
Manager and director
BoardEarliermandate already running before its first mention
Mandates as a list
- LOSANE
- Statutory director, appointed by deed of 23-07-2021, still in office
- ROSHECO
- Director (not named in the articles), appointed by deed of 23-07-2021, still in office
- Carlos de Meester de Betzenbroeck
- Manager and director, until 23-07-2021
Control
20%
This company
BELL TOWER
Equity -€95,434
Loss €16,429 in 2025
Capital
- Contribution
- €18,550
- Shares
- 1,000
- Contribution per share
- €18.55
- Equity per share
- -€95.43 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- LOBA HOLDING
- OLIPHARM
- HOLDING D'INVESTISSEMENTS ET DE PARTICIPATIONS INDUSTRIELLES
- XAG
- BELGAVIA
- LOSANE
- LEPOUTRE CONSULT
Source: lists of holdings in the owners' accounts
Articles of association
deed of 23-07-2021 (in French)- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of June at 09:20
Shareholders
5 ownersOwners 5
- Equity €13.2m Loss of €4.9m in 2025 (loss of €275,651 in 2024)20%
- Equity €143,156 Profit of €3,720 in 2025 (loss of €423 in 2024) Checked score 88Sourceaccounts OLIPHARM 202518%
- Equity €9.1m Loss of €68,165 in 2025 (profit of €150,681 in 2024)17%
- Equity €100.0m Profit of €2.7m in 2023 (profit of €937,004 in 2022)Sourceaccounts BELGAVIA 202310%
- Equity €224,245 Loss of €3,185 in 2025 (profit of €62,749 in 2024) Checked score 95Sourceaccounts XAG 202510%